Sažetak sa skupa

https://doi.org/10.15836/ccar2019.222

Outcomes in patients with heart failure with regard to statin therapy

Amina Godinjak orcid.org/0000-0002-3697-8006 ; Eurofarm Centar Medical Clinic, Sarajevo, Bosnia and Herzegovina
Miralem Đešević ; Eurofarm Centar Medical Clinic, Sarajevo, Bosnia and Herzegovina
Amer Iglica ; Clinical Center University of Sarajevo, Sarajevo, Bosnia and Herzegovina
Adis Kukuljac ; General Hospital Sarajevo, Sarajevo, Bosnia and Herzegovina

Sažetak

Objective: The aim of this study was to investigate whether statin therapy influenced outcomes in
patients with acute heart failure (HF).1,2
Patients and Methods: Eighty five patients with diagnosis of HF were included in the study. For each
patient the following data were obtained: gender, age, comorbidities and medications. New York Heart
association (NYHA) class for heart failure was determined by physician evaluation and left ventricle
ejection fraction (LVEF) was determined by echocardiography. Outcome points were: hospitalization,
in-hospital death, mortality after 6 months, 1 year and 2 years. All-cause mortality included cardiovascular
events or worsening heart failure.
Results: Mortality after 6 months, 1 year and 2 years was the most frequent in patients without statin
therapy with a statistically significant difference (p = 0.001). Progression of HF accounted for 31.7% of
mortality in patients without statin therapy.
Conclusion: Statin therapy is associated with substantially better long-term outcomes in patients with
HF.

Ključne riječi

heart failure; statin therapy; outcome

Hrčak ID:

226692

URI

https://hrcak.srce.hr/226692

Datum izdavanja:

15.10.2019.

Posjeta: 911 *